Anal Margin Carcinoma

subtype

Identifier: CI-CAN-00001792
Entity page: /cancer/anal-margin-carcinoma ↗
Edges: 8

Neighbours: 4 drugs4 trials
Drawn: 8 of 8 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Anal Margin Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Capecitabinesmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Anal Margin Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Fluorouracilsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants

Anal Margin Carcinoma studied in …STUDIED_INderived4 of 4
→ studied in	NCT04166318Phase 2 · active not recruiting Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study · condition mapped ONTOLOGY_EXACT · 4 trials mapped (4 active)	—	—	Anal Margin Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03233711Phase 3 · active not recruiting Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (4 active)	—	—	Anal Margin Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04929028Phase 2 · active not recruiting Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (4 active)	—	—	Anal Margin Squamous Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07112690NA · recruiting Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment · condition mapped CURATED_BROADER · 4 trials mapped (4 active)	—	—	Anal Margin Carcinoma	1	Observed	clinicaltrials	graph →

Anal Margin Carcinoma studied in …STUDIED_INderived4 of 4

→ studied in

NCT04166318Phase 2 · active not recruiting

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study · condition mapped ONTOLOGY_EXACT · 4 trials mapped (4 active)

—

Anal Margin Squamous Cell Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT03233711Phase 3 · active not recruiting

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (4 active)

—

Anal Margin Squamous Cell Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT04929028Phase 2 · active not recruiting

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer · condition mapped ONTOLOGY_EXACT · 4 trials mapped (4 active)

—

Anal Margin Squamous Cell Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT07112690NA · recruiting

Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment · condition mapped CURATED_BROADER · 4 trials mapped (4 active)

—

Anal Margin Carcinoma

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains